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SUMMARY
The purine deoxyribonucleoside analogue 6-chloro-8-aza-9-cyclopentylpurine has been
found to inhibit DNA, RNA, and protein synthesis independently in Escherichia coil. The
mechanism by which it inhibits DNA synthesis apparently involves a site of action in the
pathway for the formation of thymine nucleotides, since the conversion of uracil or cytosine
to thymine nucleotide derivatives in whole cells was completely abolished by 0.5 m 6-
chloro-8-aza-9-cyclopentylpurine within minutes after addition of drug to a growing culture.
In vitro studies demonstrated that concentrations of the analogue as high as 2 mt had no
effect on thymidylate synthetase activity; therefore, blockade of thymine nucleotide forma-
tion is apparently produced at an earlier step. The conversion of uracil or cytosine to nucleo-
tide derivatives other than thymine derivatives was decreased 50-60% by 6-chloro-8-aza-9-
cyclopentylpurine (0.5 mM) in whole cells, suggesting that inhibition of the formation of
ribonucleotides contributes to the blockade of both DNA and RNA synthesis observed
in vivo. Preliminary incubation of partially purified polymera.se preparations with the
analogue (1 mM) resulted in marked inhibition of RNA polymerase activity, with only slight
effects on DNA polymerase. The template function of purified DNA, however, was not
affected by incubation of DNA with drug for up to 16 hr prior to assay of template activity.
Inhibition of protein formation was also observed after incubation of components of the
cell-free protein-synthesizing system in vitro. The effect of the drug on protein synthesis
appeared to be due to an action on the 100,000 X g supernatant enzymes involved in the
polymerization of amino acids into polypeptide linkage. Neither aminoacyl-tRNA synthetase
activity nor the ability of the ribosomes to support protein synthesis was affected by 6-
chloro-8-aza-9-cyclopentylpurine. The inhibitory effects of the drug on the activity of
enzymes involved in the formation of nucleic acids and protein observed in vitro required
prior incubation with the drug and were irreversible. The data suggest that a portion of the
actions of 6-chloro-8-aza-9-cyclopentylpurine are due to a site-directed alkylation of enzymes,
leading to a blockade of enzymatic activity.
This study was supported by a grant from the 1To whom requests for reprints should be
Connecticut Division of the American Cancer addressed.
Society, and by Grants CA-02817, 5-T4-CA-5012, ‘Present address: Division of Pharmacology,
and CA-02992 from the United States Public Sloan-Kettering Institute for Cancer Research,
Health Service. New York, New York 10021.
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INTRODUCTION
The purine deoxyribonucleoside analogue
6 - chloro - 8 - aza - 9 - cyclopentylpurine has
been shown to inhibit cellular growth, the
synthesis of induced enzymes, and the
formation of DNA, RNA, and protein in
two microorganisms, Escherichia coli and
Pseadomonas testosteroni (1-3) . The
preceding paper in this series 3) examined
the effects of this agent on E. coli B and
showed that in whole cells 689 (0.4 mM)
produced immediate and essentially com-
plete inhibition of DNA synthesis; the
formation of RNA and protein was also
blocked approximately 70% by this agent.
This report (3) also provided evidence that
the inhibition of the syntheses of DNA,
RNA, and protein by this agent was in part
the result of separate metabolic lesions
induced by the drug. In the present paper,
the effects of 689 on the formation of
protein and nucleic acids were studied in
cell-free systems derived from E. coil B
cells in order to delineate the critical sub-
cellular sites of action of 689. The purine
deoxyribonucleoside analogue was observed
to react with and irreversibly inhibit several
enzymes involved in the fabrication of
nucleic acids and protein.
MATERIALS AND METHODS
Preparation of cell fractions from E.
coli B. E. coli B cells were grown at 37#{176}in
either a glucose-enriched Difco broth (4)
or a minimal salts medium (5) and
harvested in the early logarithmic phase
of growth. The cells were disrupted and
extracted, and S-30, ribosomal, and S-100
fractions were prepared by the method of
Nirenberg and Matthaei (6). The protein
content of all fractions was determined by
a modification of the method of Lowry
et at. (7).
In some cases, the ribosomal suspension
(approximately 14 absorbance units at
260 m1t) was layered on top of a 4.6-ml
linear sucrose gradient (5-20%) containing
‘The abbreviations used are: 689, 6-chloro-8-
aza-9-cyclopentylpurine: poly U. poly A. and poiy
C, polyuridylic. -adenylic, and -cytidylic acids.
respectively; DMSO, dimethyl sulfoxide.
10 mM Tris-HC1 (pH 7.8) , 10 mi magite-
sium acetate, and 60 mi KC1, and ecu-
trifuged for 2 hr at 35,000 rpm in a Spinco
SW 50L rotor. Five-drop fractions were
collected, and the absorbance at 260 m1s.
was determined.
To dissociate the 70 S particles into 50 S
and 30 S subunits, the ribosomal pellet was
suspended in 10 mM Tris-HC1 buffer, pH
7.8, containing 0.1 mi magnesium acetate,
60 mi KCI, and 6 mt /3-mercaptoethanol.
The suspension was heated at 45#{176}for 30
mm, placed on a sucrose gradient, and
centrifuged as above.
A deoxyrihonucleoprotein preparation
was isolated from the S-100 fraction by
differential and density gradient centrifu-
gation as described by Shin and Moldave
(8). The fraction contained 362 and 159
pg of protein and DNA per milliliter as
assayed by the Lowry method (7) and
diphenylamine reaction (9), respectively.
The preparation contained both DNA
polymerase (10) and RNA polymerase
activity (8).
Preparation of a cell membrane fract#{252}n
from E. coli B. A cell membrane fraction
was prepared from E. coil B cells by a
modification of the method described by
Crouch (11). A 250-ml culture of E. coli B
cells in a minimal salts medium (5) was
vigorously shaken until the absorbance of
the culture was 0.65 at 650 m1. The culture
was then centrifuged, and the cell pellet was
resuspended at 25#{176}in 5 ml of 10 m Tris-
HC1 buffer, pH 7.9, containing 1 m /3-
mercaptoethanol and 5 m EDTA. To this
suspension were added 15 ml of a 50%
solution of sucrose in the above buffer, and
lysozyme to a concentration of 0.5 mg/mI.
The mixture was incubated at 37#{176}for 40
mm and centrifuged at 10,000 rpm in a
ref rigcrated Sorvall centrifuge. Light
microscopy showed the presence of proto-
plasts in the pellet. The protoplast pellet
was then lysed by resuspension at 5#{176}in 25
ml of 10 m Tris-HCI, pH 7.9, containing
1 mM /3-mercaptoethanol, using a wide-
bore, 5-ml pipette. The resuspension process
was continued for 20 mm, when the mixture
became very viscous. The suspension was
centrifuged at 35,000 X g for 20 mm; the
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pellet was resuspended as described above,
and recentrifuged. The resulting pellet was
finally suspended in 10 ml of the above
buffer. This suspension of membranes had
a protein content of 2 mg/ml. The mem-
brane particle isolated by this method ap-
pears to be circular in shape and contains
DNA, RNA polymerase activity, and DNA
polymerase activity. The preparation
incorporated nucleoside triphosphates but
not nucleosides into DNA and RNA,
indicating the negligible presence of intact
cells.
Source of enzymes. DNA polymerase (EC
2.7.7.7), fraction IV, was prepared from late
log phase E. coil B (purchased from
General Biochemicals) according to the
method of Richardson et al. (12). Fraction
IV contained 4.5 mg of protein per milliliter
and had a specific activity of 159 units/mg
of protein. The enzyme was stored at -60#{176}
and showed no loss of activity for 9 months.
RNA polymerase (EC 2.7.7.6), fraction
4, was also prepared from commercially
grown E. coil B cells as described by
Chamberlin and Berg (13). The enzyme
preparation had a protein content of
approximately 1 mg/mi and a specific
activity of 487 units/mg of protein. The
enzyme was stored at 0-2#{176}and lost 80% of
its activity within 1 month.
Polynucleotide phosphorylase (EC 2.7.7.8)
was purified from commercial E. coli B
cells through the initial four steps described
by Williams and Grunherg-Manago (14).
The preparation had a protein content of
55 mg/mi and a specific activity of 20.2
units/mg of protein.
E. coil B thymidylate synthetase contain-
ing 8.5 units of activity per milligram of
protein was a gift from Dr. M. I. Smith
Lomax (15). E. coil alkaline phosphatase
(EC 3.1.3.1), bovine pancreatic deoxy-
ribonuclease (EC 3.1.4.5), ribonuclease (EC
2.7.7.16), trypsin (EC 3.4.4.4), and calf
thymus DNA were purchased from
Worthington Biochemical Corporation.
Enzyme assays. Purified RNA polymer-
ase was assayed by the method of Cham-
berlin and Berg (13). RNA polymerase
activity in the deoxyribonucleoprotein com-
plex and cell membrane preparation was
measured by the method of Shin and
Moldave (8) . Purified DNA polymerase
was assayed as described by Richardson
et al. (12). The activity of DNA polym-
erase in the deoxyribonucleoprotein com-
plex and in the cell membrane preparation
was measured in the manner described for
RNA polymerase except that deoxyribo-
nucleoside triphosphates w’ere utilized as
precursors. In all the assay procedures
described above, the incorporation of ‘C
labeled nucleoside triphosphate into nucleic
acid was measured using Millipore filtra-
tion (10).
Polynucleotide phosphorylase, thymidyl-
ate synthetase, deoxyribonuclease, ribo-
nuclease, trypsin, and alkaline phosphatase
were assayed for activity l) the methods
of Williams and Grunberg-Manago (14),
Smith Lomax and Greenberg (15), Kunitz
(16), Kalnitsky et al. (17), Hummel (18),
and Garen and Levinthal (19), respectively.
Amino acid incorporation studies. The
basic incubation mixture for measurement
of the rate of incorporation of amino acids
into protein by S-30, S-100, and washed
ribosomal fractions was that described pre-
viously (20), except that the radioactivity
incorporated into protein was determined
l)y Millipore filtration in the present ex-
periments. In some cases either poly U (25
p.g), poly A (25 pg), or poly C (100 g) was
employed as exogenous messenger RNA to
determine the rate of incorporation of
phenylalanine, lysine, and proline, respec-
tively, into polypeptide.
Assay of 3H-poiy U binding to ribo-
somes. 3H-Poly U (0.5-1.0 jC; 22-27 mC/
mmole) was added to a ribosomal suspen-
sion and incubated at 0#{176}for 30 mm (21).
The mixture was then layered on a sucrose
gradient and centrifuged as described
above. Five-drop fractions were collected
and assayed both for absorbance at 260 mt
and for radioactivity.
Assay of a minoacyi-tRN4 synthetases.
The activity of these enzymes in the S-100
fraction was determined by measuring the
binding of ‘4C-amino acids to tRNA using
the following reaction mixture: 500 pg of
S-100 protein, 200 ,ig of E. coli B stripped
sRNA, 0.8 1.tmole of ATP, 5 1.moles of
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sodium phosphoenolpyruvate, 10 pg of pyr-
uvate kinase, 25 jmoles of Tris-HC1 (pH
7.2) , 2 moles of f3-mercaptoethanol, 35
mmo1es each of 19 nonradioactive amino
acids, and 0.12 C of 14C-amino acid in a
total volume of 0.4 ml. The reactions were
incubated at 37#{176}for 12 mm and stopped
with 5% trichloracetic acid. The product
was isolated by the technique of Millipore
filtration, and radioactivity was measured
in a scintillation spectrometer. As controls,
some of the mixtures were heated in 5%
trichloracetic acid at 90#{176}for 20 mm before
Millipore filtration; this process solubilized
more than 97% of the radioactivity, dem-
onstrating that the major portion of the
labeled amino acid was not bound to
protein, but to tRNA.
Determination of the biosynthesis of
nucleic acid precursors in vivo. Uracil-
2-’4C (10 1kg; 5 C) was added to 5 ml of
a logarithmically growing culture of E.
coil B cells in minimal salts medium (5).
After 3 mm, the cells were harvested and
washed once with ice-cold fresh medium.
The cell pellet was extracted with cold,
0.4 N HC1O4. The mixture was centrifuged,
and the acid-soluble fraction was neutral-
ized with 8 N KOH. The insoluble KC1O4
was removed, and the supernatant was
evaporated to dryness. The residue was
dissolved in a small quantity of water, and
the entire solution was applied to Whatman
No. 1 filter paper and subjected to descend-
ing chromatography using a mixture of
1-butanol-glacial acetic acid-H20 (10:1:3)
(v/v) as the solvent. All nucleotide forms
remained at the origin, while unconverted
uracil-2-14C migrated down the paper. The
nucleotides were eluted from the origin
with distilled water, and the eluate was
incubated for 60 mm at 30#{176}in a mixture
containing 50 mi Tris-HC1 (pH 9.0), 60
mM MgSO.1, and 1 mg of lyophilized rattle-
snake venom per milliliter. The reaction
was stopped with cold acetone-glacial ace-
tic acid (9:1) and centrifuged. The result-
ing nucleosides were then separated by
paper chromatography utilizing two sepa-
rate, descending systems with (a) 1-buta-
nol-glacial acetic acid-H20 (10:1:3) (v/v)
and (b) isobutyric acid-iS x NH4OH-H,O
t66:1:33) (v/v). The areas of the chro-
matogram corresponding to uridine, cyti-
dine, deoxycytidine, thymidine, and deoxy-
uridine were located using nonradioactive
markers, and the radioactivity of each
nucleoside was determined.
Source and preparation of 689. 6-Chioro-
8-aza-9-cyclopentylpurine was prepared as
previously described (1). The material was
dissolved in dimethyl sulfoxide, and the
solution was diluted with H,O until the
final concentration of DMSO was 50%. All
further dilutions of the drug solution were
made with 50% DMSO.
Preliminary incubation of enzymes and
other factors with 689. DNA polymerase
(10 jig) was incubated at 37#{176}with 689 in
0.2 ml of reaction mixture containing
12.5% DMSO, 50 mi Tris-HC1 (pH 7.5),
25 mi (NH4) 2S04, 2.5 mi /3-mercaptoeth-
anol, and 25 jig of bovine serum albumin.
RNA polymerase (25-50 jig) was incu-
bated at 37#{176}with 689 in 0.2 ml of reaction
mixture containing 12.5% DMSO, 50 mM
Tris-HC1 (pH 7.5), 5 m MgCl2, 50 m.i
KC1, 2.5 m f3-mercaptoethanol, and 25 jig
of bovine serum albumin. Polynucleotide
phosphorylase (27 jig) was incubated with
689 at 37#{176}in 0.2 ml of reaction mixture
containing 12.5% DMSO, 50 m Tris-HC1
(pH 7.5), and 7.5 rn MgCl2. Deoxyribo-
nuclease, ribonuclease, and alkaline phos-
phatase (10 jig each) were incubated with
689 at 37#{176}in 0.2 nil of reaction mixtures
containing 12.5% DMSO and 15 m Tris-
HC1, pH 7.5. Trypsin (20 jig) was incu-
bated with 689 at 25#{176}and 37#{176}in 0.2 ml of
a reaction mixture containing 12.5%
DMSO and 15 m Tris-HC1, pH 7.5.
Deoxyribonucleoprotein (104 jig of protein
and 31 jig of DNA) was incubated at 37#{176}
with 689 in 0.2 ml of a reaction mixture
containing 17% DMSO, 15 mi Tris-HC1
(pH 7.5), 7 mM MgCl2, 50 m NaCl, and
0.7 mM /3-mercaptoethanol. DNA (30 jig)
was incubated with 689 at 37#{176}in 0.2 ml of
a reaction mixture containing 12.5%
DMSO and 15 m Tris-HC1, pH 7.5. Frac-
tions S-30 and S-100 (500-800 jig of pro-
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reaction mixture containing 12.5% Di\ISO,
15 mi Tris-HC1 (pH 7.5) , 5 mM mag-
nesium acetate, 30 m KC1, and 3 mr
/3-mercaptoethanol. Thymidylate synthe-
tase (20 jig) was incubated with 689 at 25#{176}
in 0.2 ml of reaction mixture containing
12.5% DMSO, 30 ni Tris-HC1 (pH 7.5),
0.5 mM EDTA, and 5 mi /3-mercaptoeth-
anol. The membrane preparation (200 jig
of protein) was incubated with 689 at 37#{176}
in 0.2 ml of reaction mixture containing
12.5% DMSO, 15 mi Tris-HC1, pH 7.5,
and 0.5 mi f3-mercaptoethanol. Washed
ribosomes (300-500 jig of protein) were
incubated with 689 at 37#{176}in 0.2 ml of
reaction mixture containing 12.5% DMSO,
7.5 m Tris-HC1 (pH 7.5), 7.5 mi mag-
nesium acetate, 45 mi KC1, and 4.5 mM
/3-mercaptoethanol. For each of these in-
cubations, control reaction mixtures, which
contained all the constituents listed for the
particular mixture, were incubated in the
absence of drug.
Source of chemicals. ATP, GTP, CTP,
UTP, TTP, dCTP, dATP, and dGTP were
products of P-L Biochemicals; uridine 5’-
triphosphate-2-14C (24.9 jiC/jimole), uni-
formly labeled adenosine 5’-triphosphate-
‘4C (425 jiC/jimole), uniformly labeled
cytidine 5’-triphosphate-14C (331 jiC/
jimole), thymidine 5’-triphosphate-2-14C
(30.3 jiC/p.mole), and uracil-2-14C (56 jiC/
jimole), New England Nuclear Corpora-
tion; sodium phosphoenolpyruvate, pyru-
vate kinase, sodium tetrahydrofolate, amino
acids, and ADP, Calbiochem; L-asparagine
and L-glutamine, Nutritional Biochemicals;
adenosine 5’-diphosphate-8-14C (38.6 jiC/
jimole) and deoxyuridine 5’-monophos-
phate-5-3H (10 mC/jimole), Sehwarz Bio-
Research, Inc.; polylysine and stripped E.
coli B sRNA, General Biochemicals; sodium
p-nitrophenyl phosphate and dUMP, Sigma
Chemical Company; L-phenylalanine-14C
(15.8 jiC/jimole), L-vahne-14C (6.9 C/
jimole), L-leucine-14C (7.9 p.C/jimole), L-
proline-14C (30 p.C/p.mole), L-lysine-14C
(7.5 jiC/p.mole), and L-serine-14C (7.5 jiC/
jimole), all uniformly labeled, Nuclear-
Chicago; poly U, poly C, and poly A, Miles
Chemical Company.
RESULTS
Inhibition of RNA and DNA polymerase
activity by 689. DNA, RNA, and induced
enzyme synthesis have been observed to
be strongly inhibited in E. coii B by treat-
nient with 0.4 mi 689 (3). Moreover, the
replication of T2osr bacteriophage was also
inhibited in cells which had been treated
with 689 for 15 mm prior to infection (drug
was removed from the medium before in-
fection). These findings suggested that the
purine deoxyribonucleoside analogue may
function to inhibit enzymes involved in the
synthesis of nucleic acids.
CONTROL
‘689 (I mM)
K) 0 0 40 50 60
OF
FIG. 1. Effect of 689 on the activity of R\TA
polymerase
RNA polymerase was incubated with 689 for
various periods of time and then assayed for activity
as described in MATERIALS AND METHOI)S.
The effect of 689 on the activity of
DNA-directed RNA polymerase is shown
in Fig. 1. Addition of this agent at zero
time to the RNA polymerase system had
essentially no effect on the activity of this
enzyme. When the enzyme was incul)ated
with the drug prior to assay of activity,
however, a time-dependent inhibition of
RNA polymerase activity was observed.
Thus, 90% inhibition of enzymatic activity
was produced after treatment of RNA po-
lymerase with 1 m 689 for 60 mm. Table
1 shows some of the characteristics of the
inhibition of RNA polymerase by 689; in-
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TABLE 1
Characteristics of inhibition of RNA polymerase by 689
RNA polymerase or DNA was incubated with 689 for 60 mm and then assayed for activity as described in
MATERIALS AND METHODS. In experiment 4, after the initial incubation, the RNA polymerase incubation
mixtures (2.0 ml) were dialyzed for 4 hr at 5#{176}against 100 volumes of a mixture of 12.5% DMSO, 50 m
Tris-HC1 (p11 7.5), 5 mt MgCl2, and 2.5 mM $-mercaptoethanol before assay of RNA polymerase activity.
The activity of the “no DNA” controls was subtracted from the experimental values prior to calculation ol
the percentage decrease from control. Prior incubation of enzyme without drug consistently produced r
10-15% loss of activity as compared with the unincubated enzyme. Therefore, an unincubated control w&
not included in every experiment. The experiments were not all performed at the same time, and the lower
enzymatic activity recorded for experiments 3 and 4 reflects a loss of activity with storage.
Experiment 1
No DNA




+Bovine serum albumin (50 jig)









+ 1 mi 689 and 3 mi AMP












+ 1 mM 689
-Drug + dialysis
+ 1 mM 689 + dialysis
tion of excess protein (bovine serum albu-
min), 3 mt ATP, 3 mr AMP, or 0.1M
MgC12. Dialysis of drug-treated enzyme
also failed to restore normal activity, sug-
gesting that 689 must either be tightly
bound to the enzyme or produce irreversi-
ble changes in the structure of the enzyme.
Contrary to the effect of 689 on RNA
polymerase, preliminary incubation of calf
thymus DNA with drug did not affect the
capacity of DNA to function as a template
in the RNA polymerase reaction (experi-
ment 1, Table 1). This observation, in
conjunction with the finding that multi-
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TABLE 2
Effect of 689 on enzymes involved in synthesis
of nucleic acids in E. ccli
Enzymes were incubated with 689 for 60 mm and
then assayed as described in MATERIALS AND
METHODS. The amounts of total nucleotides incor-
porated into RNA and DNA by control samples
containing incubated RNA polymerase and DNA
polymerase were 4-10 and 4-15 mjimoles, respec-
tively, for the 30-mm incubation. Results are pre-
sented asthe mean percentage inhibition ± standard
error as compared to controls where n (number of
experi ments enclosed in parentheses) exceeds 2,
and as ± range where n = 2.
Inhibition
Concentration RNA DNA
of 689 polymerase polymerase
mM % %
0.1 11 ± 5.0 (2)
0.2 24 ± 8.9 (3)
1.0 81 ± 6.9 (7) 5.3 ± 3.7 (3)
2.0 100 ± 0 (2) 23 ± 5.8 (6)
plication of bacteriophage is inhibited in
689-treated E. coli (3), suggests that 689
does not directly act on template DNA.
Table 2 shows a comparison between the
sensitivities of partially purified RNA and
DNA polymerase to the action of 689.
RNA polymerase was considerably more
sensitive to this agent than DNA polym-
erase and was significantly inhibited by a
range of concentrations of the purine de-
oxyribonucleoside analogue which inhibited
RNA synthesis in vivo. On the other hand,
DNA polymerase did not exhibit this cor-
relation between in vivo and in vitro sensi-
tivities of nucleic acid synthesis to 689.
Effect of 689 on DNA and RNA polym-
erase activities in bacterial chronzoscnne
preparations of E. coli. To be assured that
the experiments performed with purified
polymerases did not yield results peculiar
to that type of system, the effects of 689
on DNA and RNA polymerase activities
were examined in two types of chromo-
somal preparations: (a) a membrane prep-
aration containing both DNA and the
polymerase enzymes, and (b) a deoxyribo-
nucleoprotein preparation obtained from
the soluble fraction of the cell extract. The
latter DNA-protein complex containing
polymerase activity is composed of pieces
of the bacterial chromosome that have been
sheared from the cell membrane during the
extraction procedure. The results in Table
3 illustrate that the effects of drug on
polymerase activities in the chromosomal
preparations were similar to the effects on
the partially purified enzymes, in that RNA
polymerase was more sensitive to 689 than
DNA I)olymerase. Therefore, a possible mo-
leculai’ site of action of 689 in producing
inhibition of the synthesis of both RNA
and induced enzyme in vivo is RNA po-
lymerase. On the other hand, the insensitiv-
ity of DNA polymerase to this agent in
vitro suggests that another site in the path-
way for DNA synthesis is subject to inhi-
bition by 689 in vivo, since the drug has a.
greater effect OI DNA synthesis than oii
RNA synthesis in the growing cell (1-3).
Effects of 689 on other enzymes involved
in DNA synthesis. In the search for molec-
ular sites of action responsible for the inhi-
bition by 689 of the synthesis of DNA in
vivo, several enzymatic pathways involved
in the formation of DNA were tested for
sensitivity to the drug. Table 4 shows the
effect of 689 on the in vivo metabolism of
14C-uracil. The conversion of uracil to
uridine, cytidine, deoxyuridine, and deoxy-
cytidine nucleotides was inhibited by 689 to
approximately the same degree, suggesting
(a) an inhibition by the purine deoxy-
ribonucleoside analogue of the first enzy-
matic reaction (uracil phosphoribosyltrans-
ferase, EC 2.4.2.9) or of an early step in
the conversion of uracil to other nucleo-
tides, or (b) a generalized suppression of
nucleotide metabolism as the result of the
blockade of DNA synthesis. In contrast,
689 produced essentially complete blockade
of the formation of thymine nucleotides
from labeled uracil in vivo. Similar results
were obtained using 14C-cytosine as a pre-
cursor. The effect of 689 on thymine nu-
cleotide synthesis in vivo appears to be due
to some mechanism other than inhibition
of thymidylate synt.hetase, since thymidyl-
ate synthetase activity was not inhibited in
vitro when the enzyme was incubated with
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TABLE 3
Effect of 689 on DNA and RNA synthesis directed by a deoxyribonucleoprotein
complex and membrane fraction from E. coli
The deoxyribonucleoprotein complex (DNP) and the membrane preparations were incubated with 689
for 60 mm, and the DNA and RNA polymerase activities in these preparations then were determined as












j.zj.amoles % j.q.zmoles %
Experiment 1
Zero time control 60 20
DNP incubated without
drug 9760 493()
DNP incubated with 689
0.2 mi 9350 4 4380 11
1.3 mi 7180 27 1310 73
‘C-ATP
Experiment 2
Zero time control 0 0
Membrane fraction
incubated without drug 817 145
Membrane fraction
incubated with 689
0.5 mi 705 14 107 26
l.0mi 667 18 70 32
2.0 rni 385 28 38 74
of conversion of 3H-dUMP to thyniidylate.
Effects of 689 on various types of en-
zjmes. The observations of the sensitivity
of RNA polymerase to 689 and the relative
resistance of DNA polymerase and thy-
TABLE 4
Effect of 689 on metabolism of uracil-2-’4C in vvo
6-Choro-8-aza-9-cyclopentylpurine (0.5 mM) and
uracil-2-’4C were added to a growing culture of E.
coli B. After 3 miii, the cells were extracted and the
soluble fraction wa.s analyzed as described in
MATERIALS AND METHODS. Results are expressed as
the percentage of the radioactivity incorporated into








midylate synthetase to the drug prompted
further experiments to determine what
types of enzymes are affected by this
purine deoxyribonucleoside analogue. Table
5 lists the effects of 689 on a variety of
enzymes which degrade nucleic acids, nu-
cleotides, and protein. DNase and RNase
from bovine pancreas and polynucleotide
phosphorylase from E. coli B were sensi-
tive to the drug, whereas trypsin (bovine
pancreas) and E. coli alkaline phosphatase
were resistant.
Differential effects of 689 on protein syn-
thesis in vitro directed by endogenous E.
coli inRNA or by synthetic polyribonucleo-
tides. The addition of 689 at zero time to
an in vitro protein-synthesizing system (5-
30) from E. coli resulted in little effect on
the incorporation of 14C-amino acids into
protein. However, as demonstrated with
RNA polymerase, preliminary incubation
of the S-30 fraction with 689 produced an
mhil)ition of protein synthesis. The effect
Enzymes were incubated with 689 for 60 mm and then assayed as described in MATERIALS AND METHODS.
Control-incubated DNase, RNase, and alkaline phosphatase had activities of 45-60 units, 5-10 units, and
0.065 unit/5 ig of protein, respectively. Incorporation of ‘C-ADP into RNA by control-incubated poly-
nucleotide phosphorylase was approximately 100 mjmoles/reaction/15 mi Unincubated trypsin had an
activity of 36 units/lO sg of protein; the control enzyme activities after incubation for 60 mm at 37#{176}and 25#{176}
were 2 units and 22 units/lO zg of protein, respectively. The presence of 2 m 689 in the preliminary incuba-
tion media stimulated the activity of trypsin at both 25#{176}and 37#{176}(37-40 units/lO zg) as compared to the
incubated controls. Results are presented as the mean percentage inhibition from control ± standard error
where n (number of experiments enclosed in parentheses) exceeds 2, and as ± range where n = 2.
of a 60-mm incubation of S-30 with 689 on
protein synthesis in vitro using endogenous
messenger RNA is shown in Table 6. It
was observed that 689 produced a differ-
ential inhibition of ‘4C-labeled phenyl-
alanine, proline, and lysine incorporation
into protein.
It had previously been noted that 689
(0.4 mM) inhibited I)lotein synthesis in E.
coli B (3); however, since the drug also
inhibited the formation of RNA, it was
possible that the concurrent blockade of
protein synthesis was simply a reflection
of the inhibition of RNA synthesis. The
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TABLE 5









mM % % % % %
0.2 14 ± 5 (2) 43 ± 7 (2) 0 (1) 17 ± 6 (2)
1.0 34 ± 6 (2) 72.3 ± 10.7 (3) 0 (1) 46 ± 6 (2)
2.0 78. 2 ± 9.0 (4) 97.0 ± 3.0 (3) 0 ± 0 (2) 0 (1) 83 (1)
TABLE 6
Differential effects of 689 on incorporation of various amino acids into protein
directed by endogenous E. ccli mENA or synthetic po!ynucleotides
S-30 was incubated with 689 for 60 mm, after which incorporation of amino acids into protein was deter-
mined as described in MATERIALS AND METHODS. In experiments utilizing endogenous mRNA, control values
for incorporation of ‘4C-labeled phenylalanine, proline, and lysine were approximately 1200-1400 cpm,
280-600 cpm, and 500-600 cpm, respectively, per reaction mixture. Samples deproteinized at zero time were
aLso used as controls in each experiment. In experiments utilizing synthetic mRNAs, control values for
incorporation of 14C-phenylalanine, ‘4C-lysine, and ‘4C-proline were 4000-25,000 cpm, 6000-18,000 cpm, and
4000-12,000 cpm, respectively, per reaction mixture. A reaction mixture containing no polymer wa.s also
used as a control in each experiment in order to determine endogenous E. ccli mRNA activity. This residual
activity was subtracted from total radioactivity to give a measurement of the coding capacity of each
synthetic polyribonucleotide. Results are expressed as the mean percentage change from control ± standard
error where n (number of experiments enclosed in parentheses) exceeds 2, and as ± range where n = 2.
Change from control
‘4-Amino acid mRNA 0.5 mt 689 1.0 mi 689 2.0 m 689
% % %
Phenylalaniiie Endogenous +24.8 ± 17.0 (5) +13.1 ± 7.6 (6) -4.2 ± 4.6 (5
Lysine Endogenous -24.5 ± 5.2 (6) -36.4 ± 7.7 (6) -81.2 ± 8.5 (5)
Proline Endogenous -15.5 ± 5.8 (4) -37.0 ± 4.5 (4) -49.8 ± 6.9 (4)
Phenylalanine Poly U +22.4 ± 9.8 (5 +48.7 ± 16.5 (4) +74.3 ± 35.2 (6)
Lysine PolyA -11.0 ± 4 4 (3) -14.0 ± 2.1 (3) -75.3 ± 5.2(3)
Proline Poly C -9 (1) -31 (1) -83 (1)
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data in Table 6 indicate that protein syn-
thesis in vitro an be inhibited directly by
the same concentration range of 689 that
is effective in vivo.
Table 6 also shows the results obtained
\viIen the S-30 fraction (minus amino acids,
ATP-generating system, and polynucleo-
ti(lC) was treated with 689 before examina-
tion of polypeptide-synthesizing capacity
as directed by synthetic polyribonucleo-
tides. A differential effect on polypeptide
synthesis, which depended on the synthetic
polymer employed as messenger RNA, was
observed. The syntheses of both poly A-
directed 14C-polylysine and poly C-directed
‘‘C-polyproline were inhibited. Poly F-
directed peptide synthesis was either un-
changed or stimulated, but inhibition was
not observed in any of the experiments.
Effect of 689 on rthosornal structure and
function in protein. synthesie. To investi-
gate further the mechanism of action of
689 on in. vitro protein synthesis, the effect
of 689 on ribosomal structure and function
was examined. Figure 2 shows the sedi-
mentation profiles of 30 S, 50 S, and 70 S
ribosomes obtained from E. coli cells ex-
posed to 0.4 mM 689. No change in sedi-
ment.ation coefficient or profile was noted,
indicating that 689 had no apparent effect
on ribosomal structure.
The function of ribosomes after incuba-
tion for 30 mm with 689 was tested by
measuring their capacity for polypeptide
synthesis as directed by synthetic polymers.
The results of these experiments (Table 7)
0”
FRACTION NUMBER
FIG. 2. Effect of 689 on the structural integrity of
E. ccli ribosomes in vivo
E. coli B cells growing in minimal salts media
(in log phase) were treated with 0.4 mri 689 for 15
mm. Ribosomes were prepared from these cells and
subjected to sucrose density gradient centrifugation
as described in MATERIALS AND METHODS.
indicate that the ability of the ribosomes
to function in protein synthesis was only
slightly affected by 689. Again, the incor-
poration of phenylalanine into protein ap-
peared to be stimulated by 689.
The observation that 689 produced differ-
TABLE 7
Effect of 689 on capacity of E. ccli ribosomes to synthesize polypeptide
Washed ribosomes were incubated with 689 for 30 mm and then assayed for activity by measuring synthetic
polyribonucleotide-directed ‘4C-amino acid incorporation into polypeptides as described in MATERIALS AN!)
METHODS and the legend to Table 6. Results are expressed as the mean percentage change from control ±




Change f rom control
0.5 mM 689 1.0 mi 689 2.0 mi 689 3.0 mas 689
Phenylalanine Poly V
%
+6.3 ± 0.3 (4)
%
+ 11.2 ± 3.7 (5)
%
+20.6 ± 4.2 (8)
%
0 (2)
Lysine Poly A 0 (2) 0 (2) 0 (2) -33.0 ± 4.4 (3)
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FRACTION NUMBER
FIG. 3. Effect of 689 on the binding of H-poly U to
E. coli B ribosomes
‘H-Poly U was added to a ribosomal suspension
extracted from an E. coli B culture which had beeti
exposed to 689 (0.4 mu) for 15 rain. Binding of
‘Il-poly U to ribosomes was measured by density
gradient centrifugation as described in MATERIALS
AND METhODS.  DMSO control; S - - -S
689-treated.
oside analogue, the activity of S-100 in
catalyzing poly C-directed 14C-polyproline
synthesis was essentially abolished, while
activity in poly A-directed 14C-polylysine
synthesis was inhibited approximately 50%.
Experiment 2 in Table 9 shows that dial-
ysis of the S-100 fraction did not restore
activity, indicating either relatively tight
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ential effects on polypeptide synthesis
prompted an examination of the binding of
3H-poly U to 689-treated ribosomes. E.
coti ribosomes obtained from cells treated
for 15 mm with 0.4 mM 689 bound 3H-poly
I_I to a greater extent than control ribo-
somes (Fig. 3) . Ribosomes treated in vitro
with 689 also bound 3H-poly U to a greater
extent than controls. In contrast, the bind-
ing of 311-poly A to ribosomes was not
affected by 689. Therefore, the small stim-
ulation of poly U-directed 14C-polyphenyl-
alanine synthesis by 689 may be the result
of increased binding of poly U to the
ribosomes.
The effects of 689 on ribosomal activity
are small in comparison to the effects on
protein synthesis in the complete S-30
fraction. It seems likely, therefore, that the
effects of this agent on ribosomes in vivo
are not of great significance in the mecha-
nism of inhibition of protein synthesis.
Effect of 689 on activity of 8-100 frac-
tion in polypeptide synthesis. The results
obtained by incubating the S-100 (100,000
X g supernatant) fraction with various
concentrations of 689 for 30 mm are shown
in Table 8. The inhibition of S-100 activity
in directing polypeptide synthesis was simi-
lar to that observed when the S-30 fraction
had been treated with 689 (Table 6). In-
hibition of S-100 activity in vitro by 689
was attained with a concentration range of
drug which inhibited protein synthesis in
the whole cell. The kinetics of this inhibi-
tion is shown in Table 9. After 30 mm of
incubation with the purine deoxyribonucle-
TABLE 8
Effect of 689 on protein-synthesizing enzymes present in S-100 fraction of E. coli
8-100 was incubated with 689 for 30 mm and then assayed for activity by measuring synthetic polyribo-
nucleotide-directed ‘4C-amino acid incorporation into polypeptides as described in MATERIALS AND METJIOI)S
and the legend to Table 6. Results are expressed as the mean percentage change from control ± standard
error where n (number of experiments enclosed in parentheses) exceeds 2, and a.s ± range where n = 2.
‘4-Amino
acid Polymer
Change fro n control
0.3 mi 689 1.0 mi 689 2.0 mi 689 3.0 mt 689
% % % %
Phenylalanine Poly U +28.0 ± 21.0 (4) +40.5 ± 22.3 (4) +32.7 ± 20.7 (7) +13 (1)
Lysine PolyA +9.0 ± 2.0(2) 0 (3) -40.4 ± 8.2(3) -76.5 ± 6.5 (2)
Proline . Poly C -20.5 ± 6.7 (4) -54.2 ± 7.5 (4) -90.3 ± 3.3 (6) .
TABLE 9
Kinetics and irreversibility of the inhibition by 689 of 8-100 po!ypeptide-synthesizing activity
In experiment 1, S-100 was incubated with 2 m 689 and then assayed for activity by measuring synthetic
polyribonucleotide-directed ‘4C-amino acid incorporation into polypeptides as described in MATERIALS AND
METHODS. In experiment 2, S-100 was incubated with 2 mat 689 for 30 mm, and the incubation mixtures
(2.0 ml) were dialyzed for 4 hr at 5#{176}against 100 volumes of a solution containing 12.5% DMSO, 15 m
Tris-HC1 (pIT 7.5), 5 mat magnesium acetate, 30 mat KC1, and 3 mat $-mercaptoethanol before assay of 8-100
activity. Dialysis was performed only on the samples marked “+ dialysis.”
Poly C-directed Poly A-directed
‘4C-proline incorporation ‘4C-lysine incorporation
‘4C-proline
Modifications -689 +2 mat 689 -689 +2 mat 689 incorporation
cpm cpm cpm
Experiment 1
No preliminary incubation 11,123 8,744 20,470 18,330
15-mm incubation 11,047 1,794 20,349 16,301
30-mm incubation 11,051 978 23,263 12,295
60-mm incubation 11,353 683 19,414 10,713
Experiment 2
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binding or irreversible changes which de-
creased the activity of some component of
the polypeptide-synthesizing system.
Two of the enzymatic functions present
III the S-100 fraction that are presently
known to participate in polypeptide syn-
thesis are aminoacyl-tRNA synthetase and
soluble transfer factors (22) . The effects of
689 on aminoacyl-tRNA synthetase activ-
ity were studied by incubating S-100 with
drug and then measuring the binding of
the ‘4C-labeled amino acids phenylalanine,
proline, lysine, leucine, and valine to tRNA.
The results of these experiments indicated
that none of the synthetase enzymes was
sensitive to 689. Thus, the inhibition of in
vitro protein synthesis by this drug does
not appear to be due to inhibition of
aminoacyl-tRNA synthetases and may re-
flect an action of the drug on transfer
factors. The lack of a significant effect of
689 on the function of ribosomes in protein
synthesis seems to rule out peptide syn-
thetase, a ril)OsOme-aSSOciated enzymatic
activity (23), as a site of drug action. It
also seems unlikely that 689 inhibits pro-
tein formation in vivo by affecting ribo-
somal factors involved in the initiation of
protein synthesis (24) , since a marked de-
rression of polypeptide synthesis was ob-
served in the in vitro system directed by
synthetic polynucleotides, where initiation
factors are apparently not a requirement.
DISCUSSION
The structure of 6-chloro-8-aza-9-cyclo-
pentylpurine suggests that this purine de-
oxyribonucleoside analogue could affect cells
in several different ways. The presence of a
chlorine atom in position 6 of the azapurine
portion of the molecule may confer on this
agent the capacity to inhibit nucleotide
metabolism in a manner analogous to the
blockade of the conversion of inosine 5’-
phosphate to guanosine 5’-phosphate by
6-chloropurine (25, 26). Moreover, the re-
lated derivative, 9-cyclopentyladenine, has
been found to be capable of decreasing the
rate of formation of 5-phosphoribosyl 1-
pyrophosphate (27), a substrate required
in the synthesis of both purine and pyrim-
kline nucleotides. The relatively uniform
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inhibition by 689 of the conversion of
uracil and cytosine in vivo to the nucleo-
tides or uridine, cytidine, deoxycytidine,
and deoxyuridine could be the result of a
blockade of the synthesis of 5-phosphoribo-
syl 1-pyrophosphate.
The cyclopentyl ring portion of 689,
which cannot be phosphorylated, prevents
the compound from being incorporated into
DNA and RNA ; therefore, barring cleavage
to the base, 689 is incapable of altering the
function of nucleic acids in a manner anal-
ogous to 8-azaguanine, which is incorpo-
rated into and alters the function of RNA
(28-30) , and 7-deazaadenosine (tuber-
cidin) , which is incorporated into DNA
31).
The observation that 689 decreased by
approximately 50-60% the conversion of
uracil and cytosine to nucleotide metabo-
lites other than the thymine nucleotides,
while producing almost complete inhibition
of the formation of thymine nucleotides
Table 4), suggests a major site of drug
action in the pathway involved in syn-
thesizing nucleotide derivatives of thymine.
In vitro studies, however, demonstrated
that the drug had no effect on thymidylate
synthetase activity. It is conceivable, there-
fore, that inhibition of thymidylate forma-
tion by 689 is due to interference with the
synthesis of N5,N10-methylenetetrahydro-
folate, an essential coenzyme in the con-
version of dUMP to TMP. The pronounced
inhibition of the formation of thymine
nucleotides by this agent could explain the
greater effect of 689 on DNA synthesis
than on RNA synthesis noted in vivo (1-
3), since the differential effect of this agent
on nucleic acid synthesis cannot he ac-
counted for by inhibition of DNA po-
lymerase.
It had been suggested previously that
the chlorine atom in position 6 of the
purine nucleus of 689 could make the com-
pound a potent “alkylating agent” (1).
Moreover, the presence of the electroposi-
tive cyclopentyl ring and 8-aza group in
689 renders the 6-chloro atom more labile
than it is in 6-chloropurine 2’-deoxynucleo-
side and could produce a carbonium ion at
position 6 of the purine analogue. It is
conceivable, therefore, that the drug in-
hibits RNA polymerase, as well as other
sensitive enzymes, by being directed into
an active site of the enzyme as a result of
its “nucleoside” structure and then irre-
versibly binding to the enzyme by alkylat-
ing electronegative groups of the protein.
The observations that 689 does, indeed, ir-
reversibly inhibit RNA polymerase activity
in vitro, and that substitution of the chlo-
rine atom at position 6 with either hy-
droxyl, amino, or hydrazino (i.e., less ion-
izable groups) lessens the effect of the drug
Oil induced enzyme synthesis (1) and on
the inhibition of bacteriophage replication
(32) , support the concept that this agent
functions, in part, by an alkylation mecha-
nism. However, the drug does not appear
to alkylate nucleophilic centers at random.
DNA template activity, for instance, was
not affected by 689 even after incubation
of DNA with drug for up to 16 hr. Like-
wise, 689 had little effect on enzymatic
proteins such as trypsin, alkaline phos-
phatase, or DNA polymerase (Table 5),
and bovine serum albumin did not antag-
onize the drug-induced inhibition of RNA
polymerase activity (Table 1). It is pos-
sible that alkylation of these proteins oc-
curs, but that unless 689 binds to the active
site of an enzyme, a negligible effect on
enzymatic function is achieved. The fact
that 689 is effective in vitro against en-
zymes which either polymerize or degrade
nucleic acid molecules suggests that the
purine deoxyrihonucleoside structure of 689
allows for a site-directed alkylation of re-
ceptors with ensuing blockade of enzymatic
activity.
Observations in vivo (1-3) have shown
that (a) 689 produces essentially an im-
mediate effect on the syntheses of thymi-
dylate and DNA (within 3 mm), and (b)
the effects of the drug on the formation of
RNA and protein are less potent and are
dissociated from the blockade of DNA bio-
synthesis. In vitro, RNA polymerase was
not immediately inhibited by 689, but re-
quired a period of incubation with the drug.
It is interesting that the bactericidal action
of 689 on E. coli cells depends on the
length of time the cells are in contact with
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drug (3) , and this time period appears to
correlate well with the time required for
689 to inhibit completely RNA polymerase
in vitro (Fig. 1).
The agent 689 appears to exert a direct
action on protein synthesis in vitro, pos-
sibly through an action on soluble transfer
factors. It appears that the soluble transfer
factors (T factors) of E. coli have a func-
tion similar to, if not identical with, that
of the transfer factor (transferase I) de-
scribed for the rat liver system (22, 33) . It
has been demonstrated recently (33) that
transferase I of rat liver can be inhibited
by GTP, all ribonucleoside diphosphates,
and 5’-guanyl methylenediphosphonate if
the enzyme has been incubated for at least
10 mm with the nucleotides in the absence
of aminoacyl-tRNA (the presence of
aminoacyl-tRNA prevents the loss of en-
zyme activity). These results may reflect
a control mechanism for the regulation of
transferase I activity by nucleotides. The
inhibition of polypeptide synthesis by 689
in E. coli B extracts (S-100) also required
prior incubation of the drug with the
enzyme preparation, suggesting that this
agent may inhibit transferase I activity by
a similar mechanism. Dialysis of 689-
treated S-100 extracts did not restore the
capacity to fabricate polypeptides. Ibuki
and Moldave (33) have demonstrated that
nucleotide-induced loss of transferase I ac-
tivity was also irreversible.
From the above observations, it can be
seen that the purine deoxyribonucleoside
analogue 689 apparently has some unique
actions on various biosynthetic pathways
and therefore may prove to be a useful tool
in unraveling the molecular events involved
in nucleic acid and protein synthesis.
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